Show simple item record

dc.contributor.authorWHO Action Programme on Essential Drugsfr
dc.date.accessioned2012-06-16T23:31:35Z
dc.date.available2012-06-16T23:31:35Z
dc.date.created1997fr
dc.date.issued1997fr
dc.identifier.govdocWHO/DAP/97.2fr
dc.identifier.urihttps://apps.who.int/iris/handle/10665/63474
dc.descriptionWHO/DAP/97.2fr
dc.descriptionFrench onlyen
dc.description37 p.fr
dc.language.isofren
dc.publisherGenève : Organisation mondiale de la Santéfr
dc.subject.meshPharmaceutical Servicesfr
dc.subject.meshDrug Costsfr
dc.subject.meshPrivate Sectorfr
dc.subject.meshSocioeconomic Factorsfr
dc.subject.meshAlgeriafr
dc.subject.meshDrugs, Essential
dc.subject.otherPharmaceuticals and Biologicalsfr
dc.titleLa Libéralisation du secteur pharmaceutique en Algérie : effets sur la disponibilité et les prix des médicamentsfr
dc.subject.meshqualifiersupply and distribution economicsfr
dc.subject.meshqualifierorganization and administrationfr


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record